What the graph indicates is that at worldwide level most therapies are increasing at roughly the same pace as the mkt and have constant market share except onco which moves from 23 to 27 %.
Ichnos productsare cutting edge in this regard with isb 2001 leading complete remission in rats. The first line pdts 1342 and 1442 are also claimed by the company to be better than existing line of pdts.